Alkermes Public Limited Company於2011年5月4日在愛爾蘭成立為一家私人有限公司，名稱為Antler Science Two Limited（註冊號498284）。該公司是一家完全整合的全球性生物製藥公司，利用其科學專長和專有技術開發創新藥物，改善患者的治療效果。公司擁有多元化的產品組合，包括20多種商業藥物產品和大量臨床候選產品，用於治療中樞神經系統疾病，如成癮、精神分裂症和抑鬱症。
董事
名稱
職位
Richard F. Pops
Chairman,Chief Executive Officer
Brian P. McKeon
Director
David A. Daglio, Jr.
Director
David W. Anstice
Director
Frank Anders Wilson
Director
Nancy J. Wysenski
Director
Nancy L. Snyderman
Director
Richard B. Gaynor
Director
Shane Cooke
Director
Wendy L. Dixon
Director
股東
名稱
職位
Richard F. Pops
Chairman,Chief Executive Officer
Blair C. Jackson
Executive Vice President, Chief Operating Officer
C. Todd Nichols
Senior Vice President, Chief Commercial Officer
David J. Gaffin
Senior Vice President, Chief Legal Officer and Chief Compliance Officer
Iain M. Brown
Senior Vice President, Chief Financial Officer
Michael J. Landine
Senior Vice President, Corporate Development and Chief Risk Officer
Craig C. Hopkinson
Executive Vice President, Research and Development and Chief Medical Officer